» Articles » PMID: 28081244

Fever Is Associated with Reduced, Hypothermia with Increased Mortality in Septic Patients: A Meta-Analysis of Clinical Trials

Overview
Journal PLoS One
Date 2017 Jan 13
PMID 28081244
Citations 63
Authors
Affiliations
Soon will be listed here.
Abstract

Background: Sepsis is usually accompanied by changes of body temperature (Tb), but whether fever and hypothermia predict mortality equally or differently is not fully clarified. We aimed to find an association between Tb and mortality in septic patients with meta-analysis of clinical trials.

Methods: We searched the PubMed, EMBASE, and Cochrane Controlled Trials Registry databases (from inception to February 2016). Human studies reporting Tb and mortality of patients with sepsis were included in the analyses. Average Tb with SEM and mortality rate of septic patient groups were extracted by two authors independently.

Results: Forty-two studies reported Tb and mortality ratios in septic patients (n = 10,834). Pearson correlation analysis revealed weak negative linear correlation (R2 = 0.2794) between Tb and mortality. With forest plot analysis, we found a 22.2% (CI, 19.2-25.5) mortality rate in septic patients with fever (Tb > 38.0°C), which was higher, 31.2% (CI, 25.7-37.3), in normothermic patients, and it was the highest, 47.3% (CI, 38.9-55.7), in hypothermic patients (Tb < 36.0°C). Meta-regression analysis showed strong negative linear correlation between Tb and mortality rate (regression coefficient: -0.4318; P < 0.001). Mean Tb of the patients was higher in the lowest mortality quartile than in the highest: 38.1°C (CI, 37.9-38.4) vs 37.1°C (CI, 36.7-37.4).

Conclusions: Deep Tb shows negative correlation with the clinical outcome in sepsis. Fever predicts lower, while hypothermia higher mortality rates compared with normal Tb. Septic patients with the lowest (< 25%) chance of mortality have higher Tb than those with the highest chance (> 75%).

Citing Articles

The Japanese Clinical Practice Guidelines for Management of Sepsis and Septic Shock 2024.

Shime N, Nakada T, Yatabe T, Yamakawa K, Aoki Y, Inoue S Acute Med Surg. 2025; 12(1):e70037.

PMID: 39996161 PMC: 11848044. DOI: 10.1002/ams2.70037.


Unveiling the novel role of circadian rhythms in sepsis and septic shock: unexplored implications for chronotherapy.

Ramsay S, Nenke M, Meyer E, Torpy D, Young R Front Endocrinol (Lausanne). 2025; 16:1508848.

PMID: 39968295 PMC: 11832378. DOI: 10.3389/fendo.2025.1508848.


A pilot observational study of the association of 24-hour mortality with the subjective assessment of the forearm skin temperature and moisture compared to other bedside indicators of illness severity.

Nakitende I, Nabiryo J, Muhumuza A, Sikakulya F, Kellett J Resusc Plus. 2025; 21():100845.

PMID: 39811469 PMC: 11732564. DOI: 10.1016/j.resplu.2024.100845.


Investigating the effectiveness of whole-virus, protein-based, and vector-based SARS-CoV-2 vaccines on the rates of COVID-19 infection, hospitalization, and mortality: a historical cohort study in Iran.

Tanbakuchi D, Razavizadeh N, Salari M, Farkhani E, Shakeri M, Tabatabaee S BMC Infect Dis. 2025; 25(1):44.

PMID: 39789435 PMC: 11721232. DOI: 10.1186/s12879-025-10449-w.


Thermoregulation and survival during sepsis: insights from the cecal ligation and puncture experimental model.

Costa L, Trajano I, Passaglia P, Branco L Intensive Care Med Exp. 2024; 12(1):100.

PMID: 39522078 PMC: 11551088. DOI: 10.1186/s40635-024-00687-8.


References
1.
Arons M, Wheeler A, Bernard G, Christman B, Russell J, Schein R . Effects of ibuprofen on the physiology and survival of hypothermic sepsis. Ibuprofen in Sepsis Study Group. Crit Care Med. 1999; 27(4):699-707. DOI: 10.1097/00003246-199904000-00020. View

2.
Rhodes A, Lamb F, Malagon I, Newman P, Grounds R, Bennett E . A prospective study of the use of a dobutamine stress test to identify outcome in patients with sepsis, severe sepsis, or septic shock. Crit Care Med. 1999; 27(11):2361-6. DOI: 10.1097/00003246-199911000-00007. View

3.
Kirov M, Evgenov O, Evgenov N, Egorina E, Sovershaev M, Sveinbjornsson B . Infusion of methylene blue in human septic shock: a pilot, randomized, controlled study. Crit Care Med. 2001; 29(10):1860-7. DOI: 10.1097/00003246-200110000-00002. View

4.
Diekema D, Beekmann S, Chapin K, Morel K, Munson E, Doern G . Epidemiology and outcome of nosocomial and community-onset bloodstream infection. J Clin Microbiol. 2003; 41(8):3655-60. PMC: 179863. DOI: 10.1128/JCM.41.8.3655-3660.2003. View

5.
Bone R, Balk R, Cerra F, Dellinger R, Fein A, Knaus W . Definitions for sepsis and organ failure and guidelines for the use of innovative therapies in sepsis. The ACCP/SCCM Consensus Conference Committee. American College of Chest Physicians/Society of Critical Care Medicine. Chest. 1992; 101(6):1644-55. DOI: 10.1378/chest.101.6.1644. View